2020 Jul 13;117. pii: 20110. Losartan may also be used for purposes not listed in this medication guide. Outcome reported as the number of participants per arm admitted to inpatient hospital care due to COVID-19-related disease within 15 days of randomization. %%EOF 106 0 obj <> endobj A losartan recall class action lawsuit seeks reimbursement and medical monitoring for all who bought and used tablets tainted with a cancer-causing impurity. The recall is … Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04311177. Total scores range from 0 to 99 with higher scores reflecting greater levels of dyspnea during daily activity. Lakartidningen. There is no validated, unified single score and each item is evaluated individually. Drug Recall . The 33-item Severity bank assesses the severity of difficulty breathing during various specific activities (the same 33 activities assessed in Dyspnea Functional Limitations). [COVID-19 and kidney disease]. The Sandoz Inc. recall involved 100 milligram/25 milligram Losartan tablets with the lot number JB8912 and expiration date of June 2020. Outcome is reported as the mean maximum daily body temperature (in degrees Celsius) over 10 days. The FDA lab medroxyprogesterone acetate/Depo-Provera), subcutaneous contraceptive (e.g. The ordinal scale is an assessment of the clinical status at the first assessment of a given study day. h�bbd```b``�"����� L��'A$���&��-`�O�l6�l�&�4��}"��$�] ɸ����p��$���� �QD�g`�� � �S A total of 16 lots have been recalled, all at the consumer level. Wednesday's Losartan Potassium recall marks a continuation of the April 25 investigation into this medication By Haley Hunt • Published June 12, 2019 • Updated on June 12, 2019 at 8:41 pm Patients fill out a 12 question survey which is then scored by a clinician or researcher. Swedish. This time, the recall affects 5 lots: 3 lots of losartan potassium tablets and 2 lots of losartan/hydrochlorothiazide tablets. Females able to have children not currently taking a protocol allowed version of contraception: intrauterine device, Depo-formulation of hormonal contraception (e.g. Genetic and Rare Diseases Information Center. Read our, ClinicalTrials.gov Identifier: NCT04311177, Interventional The recall was issued due to one lot of Metformin being tested and showed results for NDMA levels in excess of the Acceptable Daily Intake Limit. Mental composite score is computed using the scores of twelve questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health. endstream endobj 107 0 obj <. Search List of Recalled Angiotensin II Receptor Blockers (ARBs) including Valsartan, … Study record managers: refer to the Data Element Definitions if submitting registration or results information. RECALLING FIRM: Avet Pharmaceuticals, Inc. REASON FOR RECALL: This recall is being issued due to CGMP Deviations. Class 3 Recall: Using the drug is not likely to cause adverse health consequences. Outcome reported as the mean number of days participants in each arm did not require therapeutic oxygen use. 0 Torrent Pharmaceuticals Limited announced it is including an additional 36 lots of Losartan potassium Tablets USP and 68 lots of Losartan Potassium/Hydrochlorothiazide Tablets USP in … Important recall information for Losartan Potassium 100mg Tablets We wanted to let you know that certain manufacturers have issued a recall of select lots of Losartan Potassium 100mg Tablets. Viral load is measured as number of viral genetic copies per mL. Teva Pharmaceuticals’ April recall of blood pressure and heart medication losartan has been expanded by six bulk lots after the possibly cancerous impurity NMBA was found in the active ingredient. * Drug Recall Class Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death.  (Clinical Trial), Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor), Randomized Controlled Trial of Losartan for Patients With COVID-19 Not Requiring Hospitalization, 18 Years and older   (Adult, Older Adult), Minneapolis, Minnesota, United States, 55415, M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States, 55455, Rochester, Minnesota, United States, 55415. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. Physical score is computed using the scores of twelve questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health. Published: 5:06 PM CDT April 29, 2019 ... TYLER, Texas — The FDA announced another recall for certain lots of Losartan tablets. DATE OF RECALL: April 15, 2020. Smolander J, Bruchfeld A. Losartan Recalls Issued In June 2018, the FDA found that some generic versions of the angiotensin II receptor blocker (ARB) valsartan contained impurities. UPDATE - Teva expands its voluntary recall of losartan Update [6/12/2019] Teva Pharmaceuticals is expanding its voluntary recall to include seven additional lots of losartan potassium tablets (three lots of 50 mg strength and four lots of 100 mg strength) labeled by Golden State Medical Supply. Outcome reported as the percent of participants in each arm who require hospital admission by day 15 following randomization. h�b``e``�� $��P#�0p4 ��B1�&� �=�Y�KL��/3�0v3�a����`��a��^�-+�^��00�$�d�}1���H&Uv�(�@� n�� Get the latest research information from NIH: You have reached the maximum number of saved studies (100). The SF-12 is a self-reported validated outcome measure assessing the impact of health on an individual's everyday life. The scale is as follows: 1) Death; 2) Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); 3) Hospitalized, on non-invasive ventilation or high flow oxygen devices; 4) Hospitalized, requiring supplemental oxygen; 5) Hospitalized, not requiring supplemental oxygen; 6) Not hospitalized, limitation on activities; 7) Not hospitalized, no limitations on activities. For general information, Learn About Clinical Studies. Each activity is rated in terms of degree of dyspnea (0 = no shortness of breath, 1 = mildly short of breath, 2 = moderately short of breath, 3 = severely short of breath) while engaging in the activity over the past 7 days. Outcome reported as the percent of participants in each arm who require oxygen therapy by day 15 following randomization. DRUG NAME: Losartan Potassium 50mg & 100mg Tablets . Nov. 13, 2018 -- Yet another blood pressure drug has been recalled because of fears of impurities added by a lab in China.. Drug company Sandoz says it has recalled one lot of losartan … All participants of child bearing potential enrolled in this fashion will be informed of the teratogenic risks. Participants in this arm will receive a placebo treatment. Talk with your doctor and family members or friends about deciding to join a study. Patients fill out a 12 question survey which is then scored by a clinician or researcher. It is also used to lower the risk of stroke in certain people with heart disease. Participants will collect oropharyngeal swabs every third day for the duration of study participation. Added April 10, 2020 Reason for recall: May Contain Small Rocks Products: HealthyChoice Powerbowl Chicken Feta and Farro 9.5 ounces (072655-00180) Use by Date October 19, 2020 ONLY. Update - Recall expanded. Patient reported history or electronic medical record history of kidney disease, defined as: Patient reported history or electronic medical record history of severe liver disease, defined as: To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. This prompted the first recall of valsartan medicines due to the presence of a cancer-causing substance called N-nitrosodimethylamine (NDMA) in July 2018. endstream endobj startxref Losartan is used to slow long-term kidney damage in people with type 2 diabetes who also have high blood pressure. Outcome reported as the number of participants in each arm who fall into each of 7 categories. Information provided by (Responsible Party): This is a multi-center, double-blinded study of COVID-19 infected patients randomized 1:1 to daily losartan or placebo for 10 days or treatment failure (hospital admission). %PDF-1.6 %���� Finally, the patient answers the question "I've been short of breath" using a 0-4 scale, 0 being none and the most severe. The new lot is … Currently, there is a pre-planned pooled analysis with a national trial network under development. In rare cases, Cozaar may cause a severe allergic reaction, which can include hives, itching, rash, or trouble breathing. Keywords provided by University of Minnesota: Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Why Should I Register and Submit Results? Facebook; Twitter; Email; Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. History of chronic kidney disease stage IV, Estimated Glomerular Filtration Rate (eGFR) of < 30ml/min/1.73 m2 (must be have been measured within 1 month of enrollment), Other kidney disease that in the opinion of the investigator, would affect losartan clearance, Patient reported dehydration and significantly decreased urine output in the past 72 hours, Most recent systolic blood pressure prior to enrollment <110 mmHg, Other liver disease that in the opinion of the investigator, would affect losartan clearance, Documented AST or ALT > 3 times the upper limit of normal within 3 months of randomization (if available in electronic medical record), Potassium >5.0 mmol/L (must have been measured within 1 month) of enrollment, Enrollment in another blinded randomized clinical trial for COVID. Share. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. A total of 16 lots have been recalled, all at the consumer level. The presence of NDMA in minute quantities has already led to the recall of many types of blood pressure medications, such as valsartan and losartan. … Product Recalls: April 15, 2020 – May 13, 2020. The recall of Torrent's Losartan products was initially announced December 20, 2018, and was expanded on January 3, 2019. Losartan Recall Lawsuit Losartan is a popular blood pressure medication that has been voluntarily recalled multiple times due to the presence of a human carcinogen. The company added five lots of the generic drug losartan (three lots of losartan potassium tablets and two lots of losartan potassium/hydrochlorothiazide tablets) to an April recall of more than 100 lots of the same medications. On July 2, 2020, it was announced that Major Pharmaceuticals issued a consumer-level recall on Metformin Hydrochloride Extended-Release 500mg Tablets, 10×10 Unit Dose with NDC #00904-5794-61. 142 0 obj <>stream This is part of an ongoi n g issue with angiotensin II receptor blocker (ARB) medications. Outcome is reported as the mean number of emergency department and clinic presentations combined per participant in each arm. The most common possible side effects of losartan include dizziness, stuffy nose, back pain, chest pain, diarrhea, high potassium levels, low blood pressure, low blood sugar, and tiredness (FDA, 2018-a). 129 0 obj <>/Filter/FlateDecode/ID[<5A889D6DB4DAFA4F8EA35F706136DAE1><7F38F4CC80873B44A0765239831AEB53>]/Index[106 37]/Info 105 0 R/Length 107/Prev 140842/Root 107 0 R/Size 143/Type/XRef/W[1 3 1]>>stream The recall was expanded again in April to include 36 lots of losartan potassium tablets and 68 lots of losartan potassium/hydrochlorothiazide tablets. ... Gail April … Participants will report their maximum daily oral temperature to the study team.

A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) Check out what's clicking on Foxnews.comTorrent Pharmaceuticals Limited said its Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, are affected by the recall.The ingredient detected was identified as N-Methylnitrosobutyric acid (NMBA), a known animal and potential human carcinogen. Individual Participant Data (IPD) Sharing Statement: Studies a U.S. FDA-regulated Drug Product: Studies a U.S. FDA-regulated Device Product: Product Manufactured in and Exported from the U.S.: Hospital Admission [ Time Frame: 15 days ], Change in PROMIS Dyspnea scale [ Time Frame: 10 days ], Change in SF-12 Physical Composite Score [ Time Frame: 10 days ], Change in SF-12 Mental Composite Score [ Time Frame: 10 days ], Daily Maximum Temperature [ Time Frame: 10 days ], Emergency Department/Clinic Presentations [ Time Frame: 28 days ], Disease Severity Rating Day 7 [ Time Frame: 7 days ], Disease Severity Rating Day 15 [ Time Frame: 15 days ], Disease Severity Rating Day 28 [ Time Frame: 28 days ], Viral Load by Oropharyngeal Swab Day 9 [ Time Frame: 9 days ], Viral Load by Oropharyngeal Swab Day 15 [ Time Frame: 15 days ], Ventilator-Free Days [ Time Frame: 28 days ], Therapeutic Oxygen-Free Days [ Time Frame: 28 days ], Need for Hospital Admission at 15 Days [ Time Frame: 15 days ], Need for Oxygen Therapy at 15 Days [ Time Frame: 15 days ], Positive laboratory test for COVID-19 based on local laboratory standard, Age greater than or equal to 18 years of age, One of the following: Upper respiratory symptoms (cough, rhinorrhea) or fever (>101.5) or loss of taste / smell, Randomization > 72 hours of meeting inclusion criteria, Currently taking an angiotensin converting enzyme inhibitor (ACEi) or Angiotensin receptor blocker (ARB), Prior reaction or intolerance to an ARB or ACE inhibitor, including but not limited to angioedema. Outcome reported as the mean number of days participants in each arm did not require ventilator use. A full list of the recalled products is posted on the FDA's website.Products can be identified by checking the product name, manufacturer details, and batch or lot number on the pill bottles. April 1, 2020. An … LOSARTAN POTASSIUM and HYDROCHOLOROTHIAZIDE TABLETS, USP 50mg/12.5 mg, 1000 count bottles, NDC number 13668-116-10, Lot BEF7D006, expiration date 3/2020. Losartan; 25 mg daily; oral administration. Participants in this arm will receive the study drug, Losartan. Listing a study does not mean it has been evaluated by the U.S. Federal Government. All forms of Zantac have been recalled as of April 2020. How Do I Know if my Valsartan Has Been Recalled? Choosing to participate in a study is an important personal decision. Added March 25, 2020 Reason for recall… Please remove one or more studies before adding more. Teva Pharmaceuticals has recalled an additional six lots of bulk losartan potassium tablets, expanding a nationwide recall originally initiated in April, the FDA announced June 11. Health Letter, June 2020. The lot numbers involved in the earlier recall were 180190 and 180191 (with an October 2020 expiration date) and 181597 (with a February 2021 expiration). A recall of common blood pressure medication losartan has been expanded for a fifth time after manufacturer Torrent Pharmaceuticals found a possibly carcinogenic impurity in … U.S. Department of Health and Human Services, The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. This time, the recall affects 5 lots: 3 lots of losartan potassium tablets and 2 lots of losartan/hydrochlorothiazide tablets. The affected lots are being recalled due to an unexpected impurity in the manufacturers’ active pharmaceutical ingredient (API). Losartan is used to treat high blood pressure (hypertension). COVID-19 is an emerging, rapidly evolving situation. April 17, 2020 - Buckhead Meat and Seafood of Houston - Recall of Frozen Flounder Sysco is the global leader in selling, marketing and distributing food products to restaurants, healthcare and educational facilities, lodging establishments and other customers who prepare meals away from home. Lower scores indicate greater condition severity. A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan. FDA expands blood pressure drug recall for fifth time this year. Class 2 Recall: Using the drug may cause temporary or medical reversible adverse health consequences, the probability of serious adverse health consequences is remote. According to the new guidelines, a reading of 130/80 is considered high blood pressure, a change that adds 30 million U.S. adults to the bucket of those with the condition. Contadina Pizzetas and Del Monte Veggieful Bites. Nexplanon), daily oral contraceptives with verbalized commitment to taking daily throughout the study, condom use or abstinence during the study. Losartan side effects. Randomized Controlled Trial of Losartan for Patients With COVID-19 Not Requiring Hospitalization: Actual Study Start Date : April 9, 2020: Estimated Primary Completion Date : April 1, 2021: Estimated Study Completion Date : April 1, 2021 The FDA released a list of all … The SF-12 is a self-reported validated outcome measure assessing the impact of health on an individual's everyday life. Manufacturers face thousands of lawsuits from Zantac users who claim their cancer was caused by the contaminated drug. The PROMIS Dyspnea (shortness of breath) item banks and pools assess self-reported shortness of breath in general, intensity, frequency and duration on a 0-10 scale, with 0 being no symptoms and 10 being the most severe. The latest recall comes after Torrent Pharmaceuticals expanded its recall of losartan … Placebo (microcrystalline methylcellulose, gelatin capsule); oral administration.